Back to search
Porto-sinusoidal Vascular Liver Disorder
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Porto-sinusoidal Vascular Liver Disorder trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Porto-sinusoidal Vascular Liver Disorder trials you may qualify forPorto-sinusoidal Vascular Disease (PSVD) is characterized by a portal hypertension (PH) without cirrhosis. This can induce PH complications, like digestive hemo…
Patients treated with platinum-based chemotherapy drugs have the probability of developing PSVD. The diagnosis of PSVD depends on liver biopsy. In addition, the…
Porto-sinusoidal vascular disease (PSVD) is a rare clinical entity characterized by significant portal hypertension in the absence of cirrhosis on liver histolo…
To look for the factors of exposure present prior to the onset of Porto-Sinusoidal Vascular Disease (PSVD) and which can lead to the occurrence of PSVD after re…
Platinum-based compounds are associated with several adverse effects, including Porto-Sinusoidal Vascular Disease (PSVD). Therapeutic strategies for platinum-re…